NYSE · Specialty Chemicals · USD
Ashland Inc. (ASH) Stock Analysis
Ashland Inc. (ASH) is a Specialty Chemicals stock listed on NYSE and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
ASH Key Statistics
As of Oct 21, 2026Trading
- Open
- $71.65
- Previous Close
- $71.69
- Day's Range
- 71.10–72.45
- 52-Week Range
- 47.12–78.25
- Volume
- 407.76K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.40
Valuation
- Market Cap
- $3.30B
- P/E Ratio
- 46.24
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 16.70
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 1.23
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 1.79
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 1.56
Financials (FY)
- Revenue (FY)
- $1.82B−13.68%
- Net Income (FY)
- −$845.00M−600.00%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 2.82%
- Shares Outstanding
- 45.79M
- 1-Year Return
- +45.57%
Dividend and dates
- Dividend
- $1.68+2.34%
- Ex-Dividend Date
- September 1, 2026
- Earnings Date
- November 3, 2026
- Avg Volume
- 672.52K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, ASH closed at $72.14, +45.57% over 1 year.
Ashland Inc. (ASH) has a market capitalization of $3.30B.
In fiscal 2025, ASH reported revenue of $1.82B.
ASH Stock Return by Calendar Year
Ashland Inc. (ASH) 10-year return: what $10,000 became
- 1 year
- $10,000 $14,557
- +45.57%
- 5 years
- $10,000 $8,094
- −19.06%
- 10 years
- $10,000 $15,509
- +55.09%
If you had invested $10,000 in Ashland Inc. (ASH) 10 years ago, at the close on October 21, 2016, it would have been worth $15,509 at the close on October 21, 2026: +55.09% in total, +4.49% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +24.69% |
| 2025 | −15.40% |
| 2024 | −13.71% |
| 2023 | −20.24% |
| 2022 | +1.14% |
| 2021 | +37.67% |
| 2020 | +5.05% |
| 2019 | +9.42% |
| 2018 | +0.90% |
| 2017 | +34.95% |
| 2016 (partial year) | −3.65% |
As of October 21, 2026.
ASH Revenue and Earnings by Fiscal Year
FY ends September| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $1.82B | −$845.00M | −46.3% |
| 2024 | $2.11B | $169.00M | 8.0% |
| 2023 | $2.19B | $178.00M | 8.1% |
| 2022 | $2.39B | $927.00M | 38.8% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $1.82B | $549.00M | $88.00M | −$845.00M | −46.3% |
| 2024 | $2.11B | $618.00M | $83.00M | $169.00M | 8.0% |
| 2023 | $2.19B | $668.00M | $159.00M | $178.00M | 8.1% |
| 2022 | $2.39B | $830.00M | $288.00M | $927.00M | 38.8% |
Annual figures as reported, in the company's reporting currency. As of September 30, 2025.
ASH Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $1.26 | 3 | — |
| 2025 | $1.65 | 4 | +3.1% |
| 2024 | $1.60 | 4 | +7.4% |
| 2023 | $1.49 | 4 | +14.2% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $1.26 | 3 | — |
| 2025 | $1.65 | 4 | +3.1% |
| 2024 | $1.60 | 4 | +7.4% |
| 2023 | $1.49 | 4 | +14.2% |
| 2022 | $1.31 | 4 | +11.1% |
| 2021 | $1.18 | 4 | +6.8% |
| 2020 | $1.10 | 4 | +2.3% |
| 2019 | $1.08 | 4 | +10.3% |
| 2018 | $0.98 | 4 | +12.6% |
| 2017 | $0.87 | 4 | +353.8% |
| 2016 | $0.19 | 1 | — |
Most recent payment: $0.42 per share, ex-dividend September 1, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
ASH Valuation vs Specialty Chemicals Median
Median of 70 stocks| Metric | ASH | Specialty Chemicals median | vs median |
|---|---|---|---|
| P/E | 46.24 | 28.29 | 63% above |
| P/S ratio | 1.79 | 1.59 | 13% above |
| Profit margin | 2.82% | 2.70% | 0.1 pts above |
Medians across 70 Specialty Chemicals stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
UBS Maintains Buy on Ashland, Lowers Price Target to $80
BenzingaCan Ashland (ASH) Justify Its Valuation On Its New Crop Dispersant Launch?
YahooASH's Shares Rally 30% in 6 Months: What's Driving the Upside?
YahooIs Ashland (ASH) Quietly Building Its Next Growth Engine?
YahooIs Ashland (ASH) Stock a Smart Buy for Long-Term Growth?
YahooAshland Inc. (ASH) Analyst/Investor Day - Slideshow
SeekingAlpha
All 20 articles ↓Show fewer ↑
Ashland scales Transformed Vegetable Oils technology platform in crop care, launches agrimer™ eco-disperse OD polymeric dispersant
YahooAshland Launches Its Agrimer Polymeric Dispersant For Non-Aqueous Crop Protection Formulations
BenzingaAshland Inc. (ASH) Analyst/Investor Day Transcript
SeekingAlphaAshland (ASH), Why Is Its Latest Update Drawing Attention?
YahooHere's Why You Should Retain ASH Stock in Your Portfolio Now
YahooAshland Innovation Day to be held September 17, 2026
YahooAshland to host Innovation Day for analysts and investors
YahooAshland (ASH) Up 2% Since Last Earnings Report: Can It Continue?
YahooASH Launches Permexa Sodium Caprate to Support Oral Biologics Growth
YahooAshland Launches permexa Sodium Caprate To Advance Oral Delivery Of Peptides, Biologics, And GLP‑1 Therapies
BenzingaAshland Inc.: Activist Pressure Starts To Pay Off
SeekingAlphaAshland board authorizes quarterly dividend
YahooAshland Is Said To Explore Sale After Getting Takeover Interest
BenzingaMorgan Stanley Maintains Equal-Weight on Ashland, Raises Price Target to $78
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Specialty Chemicals Stocks
Linde plc
$230.75B
SHWThe Sherwin-Williams Company
$81.88B
ECLEcolab Inc.
$80.76B
APDAir Products and Chemicals, Inc.
$67.40B
PPGPPG Industries, Inc.
$24.49B
IFFInternational Flavors & Fragrances Inc.
$23.23B
Popular Basic Materials Stocks
BHP Group Limited
$211.50B
SCCOSouthern Copper Corporation
$167.24B
RIORio Tinto Group
$141.37B
NEMNewmont Corporation
$123.47B
FCXFreeport-McMoRan Inc.
$98.94B











